Quantumleap Healthcare Collaborative
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
- Conditions
- Ductal Carcinoma in Situ
- Interventions
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- QuantumLeap Healthcare Collaborative
- Target Recruit Count
- 400
- Registration Number
- NCT06075953
- Locations
- 🇺🇸
Berkeley Outpatient Center, Berkeley, California, United States
🇺🇸UCSF, San Francisco, California, United States
🇺🇸Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
PRE-I-SPY Phase I/Ib Oncology Platform Program
- Conditions
- Metastatic Breast CancerMetastaticHormone Receptor-positive Breast CancerHormone Receptor Negative Breast CarcinomaHER2 Low Breast CancerHER2 Low Breast CarcinomaHER2-positive Breast CancerMetastatic CancerHER2-negative Breast CancerSolid Tumor, Adult
- Interventions
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- QuantumLeap Healthcare Collaborative
- Target Recruit Count
- 124
- Registration Number
- NCT05868226
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸The University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
- Conditions
- Metastatic Breast CancerMetastatic Gastrointestinal Carcinoid TumorHER-2 Protein OverexpressionHER2-positive Breast CancerHER2 LowSYD-985SYD985Vic-trastuzumab DuocarmazineMetastatic CancerMetastatic
- Interventions
- Drug: Vic-trastuzumab duocarmazine (SYD985) + paclitaxel
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- QuantumLeap Healthcare Collaborative
- Registration Number
- NCT04602117
- Locations
- 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
- Conditions
- COVID-19
- Interventions
- Biological: dornase alfaBiological: IC14Biological: narsoplimab
- First Posted Date
- 2020-07-27
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- QuantumLeap Healthcare Collaborative
- Target Recruit Count
- 1500
- Registration Number
- NCT04488081
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸UC Davis Medical Center, Davis, California, United States
🇺🇸UC Irvine Medical Center, Irvine, California, United States
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Conditions
- HER2-negative Breast CancerHormone Receptor Positive TumorAngiosarcomaTNBC - Triple-Negative Breast CancerBreast NeoplasmsBreast TumorsHER2-positive Breast CancerHormone Receptor Negative TumorBreast CancerEarly-stage Breast Cancer
- Interventions
- Drug: Standard TherapyDrug: AMG 386 with or without TrastuzumabDrug: AMG 479 (Ganitumab) plus MetforminDrug: SYD985 ([vic-]trastuzumab duocarmazine)Drug: Oral Paclitaxel + Encequidar + Dostarlimab (TSR-042) + Carboplatin with or without trastuzumabDrug: Oral Paclitaxel + Encequidar + Dostarlimab (TSR-042) with or without trastuzumabDrug: Datopotamab deruxtecan + DurvalumabDrug: Rilvegostomig + TDXdDrug: AMG 386 and Trastuzumab
- First Posted Date
- 2010-01-05
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- QuantumLeap Healthcare Collaborative
- Target Recruit Count
- 5000
- Registration Number
- NCT01042379
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Mayo Clinic - Scottsdale, Scottsdale, Arizona, United States
🇺🇸University of Arizona, Tucson, Arizona, United States